STAT+: Many patient, consumer reps on FDA advisory panels have ties to groups funded by pharma, analysis finds

Nearly 40% of FDA advisory committee meetings over a 20-year period included either a patient or consumer rep with active ties to an advocacy group funded by pharma companies.

≈